Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0X5MA
|
||||
Former ID |
DIB020030
|
||||
Drug Name |
I-BOP
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [539237] | ||
Structure |
Download2D MOL |
||||
Formula |
C23H29IO5
|
||||
InChI |
InChI=1S/C23H29IO5/c24-16-7-10-18(11-8-16)28-15-17(25)9-12-20-19(21-13-14-22(20)29-21)5-3-1-2-4-6-23(26)27/h1,3,7-12,17,19-22,25H,2,4-6,13-15H2,(H,26,27)/b3-1-,12-9+/t17-,19-,20-,21+,22-/m1/s1
|
||||
InChIKey |
UYFMSCHBODMWON-HBHIRWTLSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Thromboxane A2 receptor | Target Info | Agonist | [534478] | |
Prostaglandin F2-alpha receptor | Target Info | Agonist | [534478] | ||
Prostaglandin E2 receptor EP3 subtype | Target Info | Agonist | [534478] | ||
NetPath Pathway | IL2 Signaling Pathway | ||||
WikiPathways | GPCRs, Class A Rhodopsin-like | ||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
Small Ligand GPCRs | |||||
Signal amplification | |||||
GPCR ligand binding | |||||
GPCR downstream signalingWP98:Prostaglandin Synthesis and Regulation | |||||
GPCR downstream signaling | |||||
GPCRs, OtherWP98:Prostaglandin Synthesis and Regulation | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.